MedTrace Logo

Methionine-Restriction Diet (MRD) in Obese Adults With Metabolic Syndrome

NCT00640757 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2015-12-18

No results posted yet for this study

Summary

The purpose of this study is to determine if limiting dietary methionine (MET), one of the 10 essential amino acids (which make up proteins), causes weight loss and/or improves glucose metabolism.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Methionine deficient diet

Hominex with a low protein diet

DIETARY_SUPPLEMENT

Methionine sufficient diet

Hominex, low protein diet and methionine capsules

Sponsors & Collaborators

  • Orentreich Foundation for the Advancement of Science, Inc.

    collaborator OTHER

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Thomas W Gettys, Ph.D. · Pennington Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-12-31
Completion
2008-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00640757 on ClinicalTrials.gov